Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract - 2Find the Native Culinary Customs: Local Flavors
- 3Day to day Temporary Positions That Compensate Fairly in the US
- 4Medical team successfully delivers baby and removes massive tumor
- 5Army commander convicted of Guinea stadium massacre dies in prison
- Merck sees over $5 billion opportunity in Cidara's experimental flu drug
- Genetic study identifies earliest-known dog, dating to 15,800 years ago
- How did birds survive while dinosaurs went extinct?
- Key Little Things That Advantage Old People
- Instructions to Expand Your Smash 1500's Presentation: Tips and Deceives
- The 10 Most Famous Style Minutes on Honorary pathway
- IDF confirms Iranian missile fragments hit near Kirya, multiple cars ablaze in Ramat Gan
- The Best 15 Applications for Efficiency and Association
- Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
